Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. AGARWAL'S HEALTH CARE LTD.

NSE : AGARWALEYEBSE : 544350ISIN CODE : INE943P01029Industry : Hospital & Healthcare ServicesHouse : Private

BSE446.10-3.4 (-0.76 %)

PREV CLOSE ( ) 449.50

OPEN PRICE ( ) 446.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3435

TODAY'S LOW / HIGH ( )441.65 449.10

52 WK LOW / HIGH ( )327.4 567.8

NSE446.25-1.75 (-0.39 %)

PREV CLOSE( ) 448.00

OPEN PRICE ( ) 448.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 446.25 (20)

VOLUME 23156

TODAY'S LOW / HIGH( ) 442.50 449.95

52 WK LOW / HIGH ( )327 568

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-04 2010

Management Info

- Chairman - Managing Director

Registered Office

Address 6th Floor, Menon Eternity,1st Main Road, Austin Nagar,Alwarpet,
Chennai,
Tamil Nadu-600018

Phone 044-43787777

Email secretarial@dragarwal.com

Website www.dragarwals.co.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

07Mar Dr. Agarwals Health Care informs about
Dr. Agarwals Health Care has informed that the Exchange has received the..

27Feb Dr. Agarwals Health Care informs about
Dr. Agarwals Health Care has informed that the exchange has received the..

07Feb Dr. Agarwals Health Care informs about
Dr. Agarwals Health Care has informed about disclosure under Regulation..

06Dec Dr Agarwals Health Care informs about
Dr Agarwals Health Care has informed about disclosure under Regulation 2..

18Nov Dr. Agarwal’s Health Care informs abou
With reference to letter dated November 17, 2025, intimating the dispatc..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	140.6	219.299999999999
Gross Profit	204	385.999999999999
Operating Profit	871.5	2989.1
Net Sales	3348.4	10438.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE) 8115.80 (1.43%)	M.Cap ( in Cr)116692.75
Jupiter Life Line (BSE) 1326.50 (4.45%)	M.Cap ( in Cr)8697.33
Dr. Lal Pathlabs (BSE) 1599.85 (1.67%)	M.Cap ( in Cr)26819.53
Max Healthcare Inst (BSE) 1049.75 (2.38%)	M.Cap ( in Cr)102166.27
Global Health (BSE) 1211.95 (1.28%)	M.Cap ( in Cr)32583.50

Shareholding Pattern

	PROMOTERS	32.36%
	MUTUAL FUNDS/UTI	5.87%
	NON-INSTITUTION	1.87%
	FI/BANKS/INSURANCE	1.31%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Edelweiss Recently ...	3.39
Motilal Oswal Small...	3.33
LIC MF Healthcare F...	2.78
Canara Rob Focused ...	2.13
Motilal Oswal Multi...	1.52
Tata India Pharma &...	1.44
Invesco India Midca...	1.23

Risk Disclosures on Derivatives

Smart Quotes

DR. AGARWAL'S HEALTH CARE LTD.